Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
Explore the potential of rapid tapering in benzodiazepine detoxification through a compelling case study, offering new perspectives on treatment protocols for patients with concurrent opioid dependence.
Psychiatry October 3rd 2023
Clinical Advisor
AI-driven opioid monitoring systems are increasingly influencing medical decisions, but questions about their accuracy and potential bias persist. Learn how these tools could impact your practice and patient care.
Pain Medicine September 28th 2023
Stay abreast of the latest trends in psychopharmacology, from the over-the-counter availability of Naloxone to the deadly rise of Xylazine and the ongoing tension between federal and state marijuana laws.
Psychiatry September 27th 2023
Addiction Professional
The alarming findings on nitazenes’ impact on cardiac arrest rates and naloxone dosage requirements demand your attention; further details could change how we approach opioid overdose treatments.
Emergency Medicine September 6th 2023
SIVAD Diagnostic Medical Group’s novel drug testing strips, HarmGuard FX, are making strides in harm reduction, beginning in Delaware. These strips, a part of the wider Harm Stopper Program, signal a potential turning point in the battle against the national opioid crisis.
Psychiatry July 11th 2023
Annals of Internal Medicine
As we grapple with the opioid crisis, this comprehensive study offers crucial insights into the intersection of state medical cannabis laws and chronic noncancer pain treatment, and posits no significant changes in pain treatment due to these laws.
Pain Medicine July 11th 2023